Acciones del sector sanitario
| # | Últimos 7 días | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 1673 |  ELVN Enliven Therapeutics, Inc. - Common Stock | 51.73 USD | +1.69% | +2.76% | +21.69% | +150.39% | 3.15 B USD | ||
| 1679 |  GRAL GRAIL, Inc. - Common Stock | 73.12 USD | +1.84% | +10.44% | +27.79% | -26.14% | 3.14 B USD | ||
| 1686 |  VERA Vera Therapeutics, Inc. - Class A Common Stock | 43.13 USD | +3.93% | +0.30% | +25.05% | +45.02% | 3.10 B USD | ||
| 1710 |  CLDX Celldex Therapeutics, Inc. - Common Stock | 38.17 USD | -0.93% | -3.37% | +20.37% | +40.12% | 3.00 B USD | ||
| 1737 |  ACHC Acadia Healthcare Company, Inc. - Common Stock | 31.60 USD | +3.40% | +0.29% | +25.50% | +34.75% | 2.91 B USD | ||
| 1758 |  IRON Disc Medicine, Inc. - Common Stock | 75.01 USD | -1.28% | -4.80% | +8.62% | +29.35% | 2.87 B USD | ||
| 1772 |  RGC Regencell Bioscience Holdings Limited - Ordinary Shares | 5.65 USD | +11.88% | -2.92% | -66.71% | -61.03% | 2.79 B USD | ||
| 1785 |  ASTH Astrana Health Inc. - Common Stock | 49.00 USD | +2.85% | +4.93% | +26.81% | +98.46% | 2.73 B USD | ||
| 1792 |  SUPN Supernus Pharmaceuticals, Inc. - Common Stock | 46.66 USD | -1.46% | -2.49% | +5.83% | -13.59% | 2.71 B USD | ||
| 1794 |  KOD Kodiak Sciences Inc - Common Stock | 43.26 USD | +5.26% | +13.96% | +26.90% | +790.12% | 2.71 B USD | ||
| 1797 |  MBX MBX Biosciences, Inc. - Common Stock | 56.59 USD | -5.75% | -9.22% | +43.81% | +304.21% | 2.69 B USD | ||
| 1821 |  QURE uniQure N.V. - Ordinary Shares | 41.52 USD | +1.02% | +0.24% | +49.73% | +195.10% | 2.62 B USD | ||
| 1834 |  TMDX TransMedics Group, Inc. - Common Stock | 74.59 USD | -1.52% | +6.48% | -1.62% | -36.45% | 2.58 B USD | ||
| 1837 |  IMNM Immunome, Inc. - Common Stock | 22.59 USD | -0.92% | -6.54% | +25.29% | +163.59% | 2.56 B USD | ||
| 1842 |  ESTA Establishment Labs Holdings Inc. - Common Shares | 86.59 USD | -1.49% | -0.68% | +2.67% | +74.37% | 2.55 B USD | ||
| 1844 |  XRAY DENTSPLY SIRONA Inc. - Common Stock | 12.70 USD | -0.63% | +4.18% | +20.95% | -3.64% | 2.54 B USD | ||
| 1845 |  TRVI Trevi Therapeutics, Inc. - Common Stock | 17.91 USD | +8.41% | -8.15% | +22.09% | +161.08% | 2.54 B USD | ||
| 1846 |  CLOV Clover Health Investments, Corp. - Class A Common stock | 4.82 USD | +5.47% | -2.03% | 0.00% | +61.74% | 2.54 B USD | ||
| 1849 |  PGNY Progyny, Inc. - Common Stock | 32.36 USD | +1.19% | +5.92% | +20.25% | +65.44% | 2.53 B USD | ||
| 1852 |  GRDN Guardian Pharmacy Services, Inc. Class A Common Stock | 39.66 USD | -1.56% | +0.97% | -8.58% | +22.60% | 2.51 B USD |
Noticias Acciones del sector sanitario
Johnson & Johnson declara un dividendo trimestral de 1,34 dólares
J&J supera por 0,04$ las previsiones de BPA en el segundo trimestre del año
Elevance Health supera estimaciones, pero sus acciones caen por márgenes
Fractyl Health presenta datos de un año de su ensayo de mantenimiento de peso
Wells Fargo inicia cobertura de Pharvaris con calificación de Mejor Rendimiento
Elevance Health supera por 1,24$ las previsiones de BPA en el segundo trimestre del año
Camurus alcanza máximos de 5 meses tras superar previsiones en el Q2
Gainers Acciones del sector sanitario
 NXTC NextCure, Inc. - Common Stock | 6.58 | +201.83% |
 PRENW Prenetics Global Limited - Warrant | 0.0171 | +101.18% |
 TNONW Tenon Medical, Inc. - Warrant | 0.0107 | +42.67% |
 SHPH Shuttle Pharmaceuticals Holdings, Inc. - common stock | 4.16 | +40.54% |
 LUCYW Innovative Eyewear, Inc. - Warrants | 0.0749 | +39.48% |
 NIVFW NewGenIvf Group Limited - Warrants | 0.0350 | +32.08% |
 BMGL Basel Medical Group Ltd - ordinary shares | 8.12 | +26.68% |
 SABSW SAB Biotherapeutics, Inc. - Warrant | 0.0150 | +20.00% |
Losers Acciones del sector sanitario
 CELUW Celularity Inc. - Warrant | 0.0011 | -59.26% |
 REVBW Revelation Biosciences, Inc. - Warrant | 0.0062 | -37.37% |
 COCHW Envoy Medical, Inc. - Warrant | 0.0300 | -28.74% |
 MTNB Matinas Biopharma Holdings, Inc. Common Stock | 0.35 | -28.57% |
 WGSWW GeneDx Holdings Corp. - Warrant | 0.0013 | -23.53% |
 XAIR Beyond Air, Inc. - Common Stock | 5.77 | -22.96% |
 SPRO Spero Therapeutics, Inc. - Common Stock | 1.70 | -22.02% |
 AGEN Agenus Inc. - Common Stock | 5.08 | -16.99% |